Added to YB: 2025-10-20
Pitch date: 2025-10-16
DIM.PA [bullish]
Sartorius Stedim Biotech S.A.
+1.84%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
Market Cap
EUR 18.1B
Pitch Price
EUR 201.50
Price Target
N/A
Dividend
0.37%
EV/EBITDA
26.17
P/E
68.62
EV/Sales
6.92
Sector
Life Sciences Tools and Services
Category
growth
Sartorius Stedim Biotech (DIM France): Bioprocessing recovery gathers pace but confidence remains measured
DIM.PA (quick overview): Bioprocessing recovery accelerates with double-digit revenue growth driven by high-margin consumables. Operating leverage returns with 31%+ margins. Clean beat on revenue/earnings but mgmt keeps guidance cautious. Broad-based demand beyond restocking as biologics capacity projects restart. Trades at discount to pre-2022 multiples despite structural growth thesis intact.
Read full article (2 min)